Skip to main content

Table 1 Baseline characteristics of patients infected with COVID-19

From: Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak

  Total
(n = 156)
Survivor
(n = 100)
Non-survivor
(n = 56)
P valuea
Characteristics
 Age, years 66.0 (46.3–73.0) 58.0 (37.0–69.0) 72.0 (65.3–83.0) < 0.001
 Male, % 76 (48.7) 44(44.0) 32(57.1) 0.115
Underlying disease
 Cardiovascular disease, % 44 (28.2) 17 (17.0) 27 (48.2) < 0.001
 COPD, % 27 (17.3) 12 (12.0) 15 (26.8) 0.019
 Chronic renal disease, % 15 (9.6) 4 (4.0) 11 (19.6) 0.001
 Chronic liver disease, % 14 (9.0) 2 (2.0) 12 (21.4) < 0.001
 Cerebrovascular, % 22 (14.1) 9 (9.0) 13 (23.2) 0.014
 Diabetes, % 31 (19.9) 11 (11.0) 20 (35.7) < 0.001
 Hypertension, % 65 (41.7) 31 (31.0) 34 (60.7) < 0.001
 Cancer, % 14 (9.0) 3 (3.0) 11 (19.6) < 0.001
Initial symptoms
 Fever, % 79 (50.6) 56 (56.0) 23 (41.4) 0.074
 Cough, % 71 (45.5) 45 (45.0) 26 (46.4) 0.864
 Chest tightness, % 28 (17.9) 16 (16.0) 12 (21.4) 0.397
 Asthma, % 30 (19.2) 22 (22.0) 8 (14.3) 0.241
 Headache, % 5 (3.2) 2 (2.0) 3 (5.4) 0.351
 Myalgia, % 2 (1.3) 1 (1.0) 1 (1.8) 1.000
 Chill, % 4 (2.6) 4 (4.0) 0 (0) 0.297
 Nausea or vomiting, % 8 (5.1) 3 (3.0) 5 (8.9) 0.136
 Fatigue, % 23 (14.7) 8 (8.0) 15 (26.8) 0.002
 Diarrhea, % 2 (1.3) 1 (1.0) 1 (1.8) 0.359
 Poor appetite, % 13 (8.3) 4 (4.0) 9 (16.1) 0.014
 Disturbance of consciousness, % 4 (2.6) 0 (0) 4 (7.1) 0.015
  1. Notes: Data presented as n (%) or median (IQR)
  2. Abbreviations: COVID-19 Coronavirus Disease 2019, IQR interquartile range, COPD Chronic obstructive pulmonary disease
  3. a P values indicate differences between survivors and non-survivors. P < 0.05 was considered statistically significant